These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7005474)

  • 1. Comparison of antihypertensive effects of captopril and propranolol in essential hypertension.
    Huang CM; del Greco F; Quintanilla A; Molteni A
    JAMA; 1981 Feb; 245(5):478-82. PubMed ID: 7005474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension.
    Seedat YK
    S Afr Med J; 1979 Dec; 56(23):983-6. PubMed ID: 399093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.
    Rumboldt Z; Marinković M; Drinovec J
    Int J Clin Pharmacol Res; 1988; 8(3):181-8. PubMed ID: 2841251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril and propranolol in mild and moderate essential hypertension: preliminary report.
    Friedlander DH
    N Z Med J; 1979 Aug; 90(642):146-9. PubMed ID: 386192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossover comparison of captopril and propranolol as step 2 agents in hypertension.
    Oren A; Rotmensch HH; Vlasses PH; Riley LJ; Tadros SS; Koplin JR; Ferguson RK
    Am Heart J; 1985 Mar; 109(3 Pt 1):554-7. PubMed ID: 3883729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group.
    Pauly NC; Safar ME
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S73-6. PubMed ID: 7527106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Captopril in the treatment of essential hypertension (author's transl)].
    Lederle RM; Klaus D; Braun B
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    Arch Intern Med; 1984 Oct; 144(10):1947-53. PubMed ID: 6237623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
    Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of captopril and atenolol in essential hypertension.
    Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
    Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Am Heart J; 1983 Aug; 106(2):321-8. PubMed ID: 6346849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
    Steiner SS; Friedhoff AJ; Wilson BL; Wecker JR; Santo JP
    J Hum Hypertens; 1990 Jun; 4(3):217-25. PubMed ID: 2194029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.